NCT03465332 - Use of Diagnostic Measures in Chronic Obstructive Pulmonary Disease (COPD) in Routine Practice and Their Impact on Treatment Decisions | Biotech Hunter

Enrollment

251

Participants

Timeline

Start Date

April 19, 2018

Primary Completion Date

August 30, 2018

Study Completion Date

August 30, 2018

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

OTHER

Doctor's questionnaire

The survey of physicians will be performed using doctor's questionnaire, which will be developed by lung specialists who are not participating in the survey.

OTHER

Subject file

All subject-based data will be obtained by retrospective evaluation of subject files available at the treating lung specialist.

Trial Locations (26)

10625

GSK Investigational Site, Berlin

13057

GSK Investigational Site, Berlin

14467

GSK Investigational Site, Potsdam

14547

GSK Investigational Site, Beelitz

15517

GSK Investigational Site, Fürstenwalde

16866

GSK Investigational Site, Kyritz

18107

GSK Investigational Site, Rostock

24837

GSK Investigational Site, Schleswig

33330

GSK Investigational Site, Gütersloh

38820

GSK Investigational Site, Halberstadt

48231

GSK Investigational Site, Warendorf

56068

GSK Investigational Site, Koblenz

58706

GSK Investigational Site, Menden

60389

GSK Investigational Site, Frankfurt am Main

65183

GSK Investigational Site, Wiesbaden

76646

GSK Investigational Site, Bruchsal

82467

GSK Investigational Site, Garmisch-Partenirchen

89073

GSK Investigational Site, Ulm

90489

GSK Investigational Site, Nuremberg

03050

GSK Investigational Site, Cottbus

04103

GSK Investigational Site, Leipzig

04157

GSK Investigational Site, Leipzig

04357

GSK Investigational Site, Leipzig

06108

GSK Investigational Site, Halle

06333

GSK Investigational Site, Hettstedt

06886

GSK Investigational Site, Wittenberg